DealsHIG Capital to sell Canadian CDMO BioVectra for $925mBioVectra is a biotechnology and pharmaceutical CDMO.ByIrien Joseph29 July 2024•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsCanadaNorth AmericaHealthcareBriefs